Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Monomer, MALS verified)
Artikelnummer:
ABS-HL1-H82EB-200UG
- Bilder (3)
| Artikelname: | Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Monomer, MALS verified) |
| Artikelnummer: | ABS-HL1-H82EB-200UG |
| Hersteller Artikelnummer: | HL1-H82Eb-200ug |
| Alternativnummer: | ABS-HL1-H82EB-200UG |
| Hersteller: | AcroBiosystems |
| Wirt: | Human |
| Kategorie: | Proteine/Peptide |
| Spezies Reaktivität: | Human |
| Konjugation: | Unconjugated |
| Wilms tumor gene 1 (WT1),is an attractive target antigen for leukemia and solid cancer. WT1specific adoptive immunotherapy has developed for tumor treatment in recent years. WT1 has been proved wildly expressed in breast, colon and ovarian cancer. It participates in cell growth, differentiation and apoptosis regulation. The Human HLAA*0201 WT1 (RMFPNAPYL) complex Protein is a complex of HLAA*0201 of the MHC Class I, B2M and RMFPNAPYL peptide of the WT1. - Proteine/Peptide |
| Molekulargewicht: | 36.3 kDa and 11.7 kDa |
| Tag: | C-10*His & C-Avi |
| NCBI: | 59606 |
| Puffer: | PBS, pH7.4 |
| Reinheit: | 90% |
| Formulierung: | Powder |
| Target-Kategorie: | HLA-A*0201 & B2M & WT-1 (RMFPNAPYL) |



